http://www.immortalitymedicine.tv Thu, 29 Jul 2010 08:17:30 +0000 http://wordpress.org/?v=2.8.4 en hourly 1 http://www.immortalitymedicine.tv/merck-grants-license-to-labcorp-for-development-of-genetic-test-to-predict-response-of-hcv-patients/ http://www.immortalitymedicine.tv/merck-grants-license-to-labcorp-for-development-of-genetic-test-to-predict-response-of-hcv-patients/#comments Thu, 29 Jul 2010 04:42:31 +0000 admin http://www.immortalitymedicine.tv/merck-grants-license-to-labcorp-for-development-of-genetic-test-to-predict-response-of-hcv-patients/ Merck announced a non-exclusive license agreement with Laboratory Corporation of America Holdings (LabCorp) for the commercialization of a genetic test that may help predict the response of patients with Hepatitis C virus (HCV) infection to peginterferon alpha-based therapy.

]]> http://www.immortalitymedicine.tv/merck-grants-license-to-labcorp-for-development-of-genetic-test-to-predict-response-of-hcv-patients/feed/ 0 http://www.immortalitymedicine.tv/genetic-screen-for-hepatitis-c-virus-hcv-protease-inhibitors/ http://www.immortalitymedicine.tv/genetic-screen-for-hepatitis-c-virus-hcv-protease-inhibitors/#comments Tue, 27 Jul 2010 08:15:44 +0000 admin http://www.immortalitymedicine.tv/genetic-screen-for-hepatitis-c-virus-hcv-protease-inhibitors/ A novel in vivo genetic screen for Hepatitis C virus (HCV) Protease Inhibitors has been developed based on the concerted co-expression of a reporter gene, recombinant Hepatitis C virus (HCV) non-structural 3 (NS3) protease and a potential inhibitor…

]]> http://www.immortalitymedicine.tv/genetic-screen-for-hepatitis-c-virus-hcv-protease-inhibitors/feed/ 0 http://www.immortalitymedicine.tv/brainlab-launches-exactrac-infrared-monitoring-device-for-patient-positioning-during-radiation-therapy/ http://www.immortalitymedicine.tv/brainlab-launches-exactrac-infrared-monitoring-device-for-patient-positioning-during-radiation-therapy/#comments Tue, 27 Jul 2010 08:15:44 +0000 admin http://www.immortalitymedicine.tv/brainlab-launches-exactrac-infrared-monitoring-device-for-patient-positioning-during-radiation-therapy/ Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.

]]> http://www.immortalitymedicine.tv/brainlab-launches-exactrac-infrared-monitoring-device-for-patient-positioning-during-radiation-therapy/feed/ 0 http://www.immortalitymedicine.tv/qrxpharma-reports-positive-outcome-of-european-scientific-advice-meetings-on-moxduo-ir-pain-therapy/ http://www.immortalitymedicine.tv/qrxpharma-reports-positive-outcome-of-european-scientific-advice-meetings-on-moxduo-ir-pain-therapy/#comments Tue, 27 Jul 2010 08:15:44 +0000 admin http://www.immortalitymedicine.tv/qrxpharma-reports-positive-outcome-of-european-scientific-advice-meetings-on-moxduo-ir-pain-therapy/ QRxPharmareported today positive outcomes of its European Scientific Advice meetings on the development and registration of MoxDuo IR, an immediate release Dual-Opioid™ pain therapy. The Company is currently completing pivotal Phase 3 trials required for filing a New Drug Application (NDA) for MoxDuo IR with the United States Food and Drug Administration (FDA).

]]> http://www.immortalitymedicine.tv/qrxpharma-reports-positive-outcome-of-european-scientific-advice-meetings-on-moxduo-ir-pain-therapy/feed/ 0 http://www.immortalitymedicine.tv/most-men-with-low-risk-prostate-cancer-receive-aggressive-treatment/ http://www.immortalitymedicine.tv/most-men-with-low-risk-prostate-cancer-receive-aggressive-treatment/#comments Tue, 27 Jul 2010 08:15:44 +0000 admin http://www.immortalitymedicine.tv/most-men-with-low-risk-prostate-cancer-receive-aggressive-treatment/ Most men who are diagnosed with prostate cancer appear to under undergo aggressive therapy, even if they have a low prostate-specific antigen (PSA) level and low-risk disease, according to a report in the July 26 issue of Archives of Internal Medicine.

]]> http://www.immortalitymedicine.tv/most-men-with-low-risk-prostate-cancer-receive-aggressive-treatment/feed/ 0 http://www.immortalitymedicine.tv/calibra-medicals-finesse-insulin-patch-pen-receives-fda-clearance-for-use-with-novo-nordisks-novolog/ http://www.immortalitymedicine.tv/calibra-medicals-finesse-insulin-patch-pen-receives-fda-clearance-for-use-with-novo-nordisks-novolog/#comments Tue, 27 Jul 2010 08:15:44 +0000 admin http://www.immortalitymedicine.tv/calibra-medicals-finesse-insulin-patch-pen-receives-fda-clearance-for-use-with-novo-nordisks-novolog/ Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk’s Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra’s novel bolus-only patch-pen is a …

]]> http://www.immortalitymedicine.tv/calibra-medicals-finesse-insulin-patch-pen-receives-fda-clearance-for-use-with-novo-nordisks-novolog/feed/ 0 http://www.immortalitymedicine.tv/full-face-transplant-spaniard-displays-new-look/ http://www.immortalitymedicine.tv/full-face-transplant-spaniard-displays-new-look/#comments Tue, 27 Jul 2010 04:05:56 +0000 admin http://www.immortalitymedicine.tv/full-face-transplant-spaniard-displays-new-look/ Oscar (right), a man who underwent a full-face transplant in April, poses with the Spanish Dr. Joan Barret for the photographers as he appears in public for the first time in a news conference in Barcelona, Spain, Monday, July 26, 2010. (AP) MADRID (AP) – A Spanish man who underwent the world’s first full face transplant appeared before TV cameras Monday for the first time since his surgery …

]]> http://www.immortalitymedicine.tv/full-face-transplant-spaniard-displays-new-look/feed/ 0 http://www.immortalitymedicine.tv/new-face-a-world-first/ http://www.immortalitymedicine.tv/new-face-a-world-first/#comments Mon, 26 Jul 2010 23:10:47 +0000 admin http://www.immortalitymedicine.tv/new-face-a-world-first/ First full face transplant for Spanish man who accidentally shot himself five years ago.

]]> http://www.immortalitymedicine.tv/new-face-a-world-first/feed/ 0 http://www.immortalitymedicine.tv/aggressive-treatment-for-prostate-cancer-is-the-norm/ http://www.immortalitymedicine.tv/aggressive-treatment-for-prostate-cancer-is-the-norm/#comments Mon, 26 Jul 2010 21:44:32 +0000 admin http://www.immortalitymedicine.tv/aggressive-treatment-for-prostate-cancer-is-the-norm/ More than 75% of men diagnosed with low-risk prostate cancer undergo aggressive treatment — either complete removal of the prostate or radiation therapy, according to a new study.

]]> http://www.immortalitymedicine.tv/aggressive-treatment-for-prostate-cancer-is-the-norm/feed/ 0 http://www.immortalitymedicine.tv/test-could-predict-which-children-with-t-cell-all-are-best-candidates-for-clinical-trials/ http://www.immortalitymedicine.tv/test-could-predict-which-children-with-t-cell-all-are-best-candidates-for-clinical-trials/#comments Sun, 25 Jul 2010 01:26:29 +0000 admin http://www.immortalitymedicine.tv/test-could-predict-which-children-with-t-cell-all-are-best-candidates-for-clinical-trials/ A genetic clue uncovered by scientists enables doctors to predict, for the first time, which children with T-cell acute lymphoblastic leukemia (T-ALL) are unlikely to benefit from standard chemotherapy for the disease and should therefore be among the first to receive new treatments in future clinical trials.

]]> http://www.immortalitymedicine.tv/test-could-predict-which-children-with-t-cell-all-are-best-candidates-for-clinical-trials/feed/ 0 http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-on/ http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-on/#comments Sat, 24 Jul 2010 08:17:14 +0000 admin http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-on/ Women who had radiation treatment as children have a higher risk of stillbirth and neonatal death, study finds

]]> http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-on/feed/ 0 http://www.immortalitymedicine.tv/guest-commentary-collier-county-and-jackson-lab-best-of-both-worlds/ http://www.immortalitymedicine.tv/guest-commentary-collier-county-and-jackson-lab-best-of-both-worlds/#comments Sat, 24 Jul 2010 08:17:14 +0000 admin http://www.immortalitymedicine.tv/guest-commentary-collier-county-and-jackson-lab-best-of-both-worlds/ As dean of the only medical school on the west coast of Florida, I’m incredibly excited about bringing the world’s leading genetic research laboratory to Collier County.

]]> http://www.immortalitymedicine.tv/guest-commentary-collier-county-and-jackson-lab-best-of-both-worlds/feed/ 0 http://www.immortalitymedicine.tv/it-took-5-years-to-patent-corneal-stem-cell-therapy/ http://www.immortalitymedicine.tv/it-took-5-years-to-patent-corneal-stem-cell-therapy/#comments Fri, 23 Jul 2010 20:30:54 +0000 admin http://www.immortalitymedicine.tv/it-took-5-years-to-patent-corneal-stem-cell-therapy/ It took five years, more than seven challenges from scientists from across the globe and several rounds of arguments with an expert committee before a few city-based scientists managed to obtain the process patent for growing stem cells of the cornea on a synthetic gel to be used in transplants.

]]> http://www.immortalitymedicine.tv/it-took-5-years-to-patent-corneal-stem-cell-therapy/feed/ 0 http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-in-life/ http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-in-life/#comments Fri, 23 Jul 2010 20:30:23 +0000 admin http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-in-life/ Women who, as children, had radiation treatment on reproductive areas for cancer are more likely to experience a stillbirth or have a baby die in the first four weeks of life, a new report says.

]]> http://www.immortalitymedicine.tv/childhood-radiation-therapy-linked-to-stillbirths-later-in-life/feed/ 0 http://www.immortalitymedicine.tv/radiation-for-childhood-cancer-can-boost-risk-of-stillbirth-later/ http://www.immortalitymedicine.tv/radiation-for-childhood-cancer-can-boost-risk-of-stillbirth-later/#comments Thu, 22 Jul 2010 23:09:12 +0000 admin http://www.immortalitymedicine.tv/radiation-for-childhood-cancer-can-boost-risk-of-stillbirth-later/ THURSDAY, July 22 (HealthDay News) — Women who are childhood cancer survivors face a greater risk of having a stillborn child if their uterus or ovaries were exposed to radiation during their treatments, a new study finds.

]]> http://www.immortalitymedicine.tv/radiation-for-childhood-cancer-can-boost-risk-of-stillbirth-later/feed/ 0 http://www.immortalitymedicine.tv/women-exposed-to-radiation-therapy-as-children-prone-to-stillbirths/ http://www.immortalitymedicine.tv/women-exposed-to-radiation-therapy-as-children-prone-to-stillbirths/#comments Thu, 22 Jul 2010 22:41:36 +0000 admin http://www.immortalitymedicine.tv/women-exposed-to-radiation-therapy-as-children-prone-to-stillbirths/ Thanks to advances in medicine, many children and adolescents who were diagnosed with cancer years ago are now surviving to adulthood and wanting to start families themselves. But how does exposure to radiation used to treat cancer early in life affect the chances of that person’s own baby being stillborn or dying very soon after birth? These questions are answered in an Article published Online …

]]> http://www.immortalitymedicine.tv/women-exposed-to-radiation-therapy-as-children-prone-to-stillbirths/feed/ 0 http://www.immortalitymedicine.tv/dermagenoma-announces-availability-of-psoriasisdx-genetic-test-as-ce-marked-product-for-psa/ http://www.immortalitymedicine.tv/dermagenoma-announces-availability-of-psoriasisdx-genetic-test-as-ce-marked-product-for-psa/#comments Thu, 22 Jul 2010 08:18:11 +0000 admin http://www.immortalitymedicine.tv/dermagenoma-announces-availability-of-psoriasisdx-genetic-test-as-ce-marked-product-for-psa/ Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis is now available as a CE Marked product under the European In Vitro Diagnostic Directive.

]]> http://www.immortalitymedicine.tv/dermagenoma-announces-availability-of-psoriasisdx-genetic-test-as-ce-marked-product-for-psa/feed/ 0 http://www.immortalitymedicine.tv/health-canada-grants-osiris-priority-review-for-prochymal-nds/ http://www.immortalitymedicine.tv/health-canada-grants-osiris-priority-review-for-prochymal-nds/#comments Thu, 22 Jul 2010 08:18:11 +0000 admin http://www.immortalitymedicine.tv/health-canada-grants-osiris-priority-review-for-prochymal-nds/ Osiris Therapeutics, Inc. announced today that the Biologics and Genetic Therapies Directorate of Health Canada has completed its initial evaluation and accepted for full review the company’s New Drug Submission (NDS) of Prochymal (remestemcel-L), an adult stem cell therapy for the treatment of graft vs. host disease (GvHD). Based on a separate review of summary clinical data, Health Canada has …

]]> http://www.immortalitymedicine.tv/health-canada-grants-osiris-priority-review-for-prochymal-nds/feed/ 0 http://www.immortalitymedicine.tv/la-jolla-institute-forms-partnership-to-investigate-potential-new-therapy-for-sickle-cell-disease/ http://www.immortalitymedicine.tv/la-jolla-institute-forms-partnership-to-investigate-potential-new-therapy-for-sickle-cell-disease/#comments Thu, 22 Jul 2010 08:18:11 +0000 admin http://www.immortalitymedicine.tv/la-jolla-institute-forms-partnership-to-investigate-potential-new-therapy-for-sickle-cell-disease/ Researchers from the La Jolla Institute for Allergy & Immunology have joined forces with the Dana-Farber Cancer Institute in Boston and Washington University in St. Louis to investigate a potential new therapy for sickle cell disease, a severe and chronic illness affecting more than 70,000 Americans and several million people worldwide.

]]> http://www.immortalitymedicine.tv/la-jolla-institute-forms-partnership-to-investigate-potential-new-therapy-for-sickle-cell-disease/feed/ 0 http://www.immortalitymedicine.tv/inra-genomic-platform-core-facility-now-provides-services-on-fluidigms-biomark-system-for-genetic-analysis/ http://www.immortalitymedicine.tv/inra-genomic-platform-core-facility-now-provides-services-on-fluidigms-biomark-system-for-genetic-analysis/#comments Thu, 22 Jul 2010 08:18:11 +0000 admin http://www.immortalitymedicine.tv/inra-genomic-platform-core-facility-now-provides-services-on-fluidigms-biomark-system-for-genetic-analysis/ Fluidigm Corporation today announced that the Toulouse Midi-Pyrénées Genomic Platform – Genotoul INRA core facility is now providing a wide range of services on a BioMark™ System for Genetic Analysis to a wide range of French researchers. These services include SNP genotyping, gene expression analysis and digital PCR quantification of DNA libraries for next-generation sequencing. The INRA has …

]]> http://www.immortalitymedicine.tv/inra-genomic-platform-core-facility-now-provides-services-on-fluidigms-biomark-system-for-genetic-analysis/feed/ 0 http://www.immortalitymedicine.tv/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children/ http://www.immortalitymedicine.tv/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children/#comments Wed, 21 Jul 2010 04:52:44 +0000 admin http://www.immortalitymedicine.tv/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children/ Children given a hormone growth factor alongside chemotherapy for the aggressive cancer neuroblastoma are less likely to suffer a potentially deadly side-effect, according to a major international study published today (Tuesday) in the Journal of Clinical Oncology.

]]> http://www.immortalitymedicine.tv/new-therapy-to-reduce-side-effects-of-neurobastoma-in-children/feed/ 0 http://www.immortalitymedicine.tv/depression-overlooked-in-patients-with-hepatitis-c-compromising-hcv-therapy/ http://www.immortalitymedicine.tv/depression-overlooked-in-patients-with-hepatitis-c-compromising-hcv-therapy/#comments Tue, 20 Jul 2010 21:29:06 +0000 admin http://www.immortalitymedicine.tv/depression-overlooked-in-patients-with-hepatitis-c-compromising-hcv-therapy/ Researchers from Denmark, Sweden, Norway and Finland (the NORDynamIC project group) have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression compromises the outcome of HCV therapy. A second U.S. study found that patients with chronic infection had lower (work …

]]> http://www.immortalitymedicine.tv/depression-overlooked-in-patients-with-hepatitis-c-compromising-hcv-therapy/feed/ 0 http://www.immortalitymedicine.tv/how-saving-your-babys-umbilical-cord-can-save-lives/ http://www.immortalitymedicine.tv/how-saving-your-babys-umbilical-cord-can-save-lives/#comments Mon, 19 Jul 2010 08:14:42 +0000 admin http://www.immortalitymedicine.tv/how-saving-your-babys-umbilical-cord-can-save-lives/ New mail-in donations aim to keep valuable stem cells out of the trash

]]> http://www.immortalitymedicine.tv/how-saving-your-babys-umbilical-cord-can-save-lives/feed/ 0 http://www.immortalitymedicine.tv/immunacias-genetic-immunity-reports-phase-ii-data-on-dermavir-a-therapeutic-vaccine-for-hivaids-during-the-xviii/ http://www.immortalitymedicine.tv/immunacias-genetic-immunity-reports-phase-ii-data-on-dermavir-a-therapeutic-vaccine-for-hivaids-during-the-xviii/#comments Mon, 19 Jul 2010 07:00:00 +0000 admin http://www.immortalitymedicine.tv/immunacias-genetic-immunity-reports-phase-ii-data-on-dermavir-a-therapeutic-vaccine-for-hivaids-during-the-xviii/ BUDAPEST, Hungary & MCLEAN, Va.—-Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company’s novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria.

]]> http://www.immortalitymedicine.tv/immunacias-genetic-immunity-reports-phase-ii-data-on-dermavir-a-therapeutic-vaccine-for-hivaids-during-the-xviii/feed/ 0 http://www.immortalitymedicine.tv/cancer-drug-olaparib-shows-early-promise/ http://www.immortalitymedicine.tv/cancer-drug-olaparib-shows-early-promise/#comments Mon, 19 Jul 2010 02:15:55 +0000 admin http://www.immortalitymedicine.tv/cancer-drug-olaparib-shows-early-promise/ A novel therapy designed to exploit the renegade power of malignant cells showed remarkable effectiveness against advanced ovarian and breast cancer in two small studies

]]> http://www.immortalitymedicine.tv/cancer-drug-olaparib-shows-early-promise/feed/ 0